Healthcare -
Biotechnology - NASDAQ - US
$ 5.31
-0.562 %
$ 165 M
Market Cap
-2.0
P/E
ACRV - COST OF REVENUE
Cost of Revenue ACRV - Acrivon Therapeutics, Inc. Common Stock
536 K
LAST VALUE
-19.74%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR